Finance Minister enhances Primary Dealers system to strengthen government securities market, alleviate debt service burden    Valu Partners with Magdi Yacoub Heart Foundation to streamline donations for New Cairo centre    Australia retail sales inch up 0.1% in April    UK retail sales rebound in May – CBI survey    ECB should favour QE in Crisis – Schnabel    Kremlin accuses NATO of direct involvement in Ukraine conflict as fighting intensifies    SCZONE aims to attract more Korean companies in targeted industrial sectors: Chairperson    30.2% increase in foreign workers licensed in Egypt's private, investment sectors in 2023: CAPMAS    Cairo investigates murder of Egyptian security personnel on Rafah border: Military spox    Al-Sisi receives delegation from US Congress    Madinaty's inaugural Skydiving event boosts sports tourism appeal    Russia to build Uzbek nuclear plant, the first in Central Asia    Arab leaders to attend China-Arab States Co-operation Forum in Beijin    East Asian leaders pledge trade co-operation    Abdel Ghaffar highlights health crisis in Gaza during Arab meeting in Geneva    Tunisia's President Saied reshuffles cabinet amidst political tension    Hassan Allam Construction Saudi signs contract for Primary Coral Nursery in NEOM    US Embassy in Cairo brings world-famous Harlem Globetrotters to Egypt    Instagram Celebrates African Women in 'Made by Africa, Loved by the World' 2024 Campaign    US Biogen agrees to acquire HI-Bio for $1.8b    Egypt to build 58 hospitals by '25    Giza Pyramids host Egypt's leg of global 'One Run' half-marathon    Madinaty to host "Fly Over Madinaty" skydiving event    Coppola's 'Megalopolis': A 40-Year Dream Unveiled at Cannes    World Bank assesses Cairo's major waste management project    Egyptian consortium nears completion of Tanzania's Julius Nyerere hydropower project    Sweilam highlights Egypt's water needs, cooperation efforts during Baghdad Conference    Swiss freeze on Russian assets dwindles to $6.36b in '23    Egyptian public, private sectors off on Apr 25 marking Sinai Liberation    Debt swaps could unlock $100b for climate action    Amal Al Ghad Magazine congratulates President Sisi on new office term    Financial literacy becomes extremely important – EGX official    Euro area annual inflation up to 2.9% – Eurostat    BYD، Brazil's Sigma Lithium JV likely    UNESCO celebrates World Arabic Language Day    Motaz Azaiza mural in Manchester tribute to Palestinian journalists    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Swine flu vaccine to take months to produce, says WHO
Published in Daily News Egypt on 19 - 05 - 2009

GENEVA: Drug manufacturers won t be able to start making a swine flu vaccine until mid-July at the earliest, months later than previous predictions, the World Health Organization said Tuesday.
The disclosure that making a swine flu vaccine is proving more difficult than experts first thought came as UN Secretary-General Ban Ki-moon and WHO chief Dr Margaret Chan met Tuesday with representatives from up to 30 pharmaceutical companies to discuss the subject.
Health officials from around the world are attending WHO s annual meeting in Geneva this week to discuss the outbreak that has infected 9,830 people in over 40 countries, killing 79 of them.
According to vaccine experts convened by WHO last week, swine flu virus is not growing very fast in laboratories, making it difficult for scientists to get the key ingredient they need for a vaccine, the seed stock from the virus.
The flu experts said vaccine manufacturers will not be ready to produce a swine flu vaccine until mid-July at the earliest, the agency reported Tuesday on its Web site. Previously, WHO officials had estimated that production could start in late May.
Experts also found no evidence that regular flu vaccines offer any protection against swine flu.
Vaccine experts estimated under the best conditions, they could produce nearly 5 billion doses of swine flu vaccine over a year after beginning full-scale production.
In that situation, the UN might have access to up to 400 million doses for poor countries. The rest of the vaccines would presumably go to wealthy contras who have already signed deals to get the pandemic vaccine as soon as it is available.
Mass producing a pandemic vaccine would be a gamble, as it would take away manufacturing capacity for the seasonal flu vaccine that kills up to 500,000 people each year. Some experts have wondered whether the world really needs a vaccine for an illness that so far appears mild.
Chan said Monday it would be impossible to produce enough vaccine for all 6.8 billion people on the planet. That suggests a possible global scramble where rich countries outbid poorer nations for the vaccine, leaving them unprotected against the virus.
It is absolutely essential that countries do not squander these precious resources through poorly targeted measures, said Chan.
Unlike other countries such as Britain, the United States has so far refrained from reserving its share of any new vaccine.
At this point we have not placed orders for vaccine, US Health and Human Services Secretary Kathleen Sebelius told reporters in Geneva.
There is still so much uncertainty about this virus that it is really premature for us to even make a determination of how many people would appropriately be vaccinated, in what order, how many doses would be required, and at what point.
These are the issues Ban and Chan will discuss with vaccine makers, believed to include top producers Sanofi-Aventis, GlaxoSmithKline and Baxter International as well as drugmakers from developing countries.
On Monday, dozens of governments lobbied WHO to tread carefully before next raising its swine flu alert to the highest pandemic level of phase 6. The level currently stands at phase 5 - saying a global outbreak is imminent.
Britain, Japan, China and others said Monday that declaring a global outbreak could cause unnecessary panic and confusion, especially since the virus has turned out to be less deadly than feared.
The expert group emphasized that WHO s declaration of a pandemic should not automatically force vaccine makers to switch from making regular flu vaccine to pandemic vaccine. In addition, they said even if swine flu vaccine production began, that did not mean that countries should start immunizing large groups of people.
The experts told WHO that it should come up with targeted advice on which groups of people need the vaccine the most and should get it first.
They also planned to meet again in several weeks to decide whether large-scale production of swine flu vaccine should begin.
Since the outbreak began last month, 79 people have died from the disease - 72 in Mexico, five in the US, one in Canada and one in Costa Rica, WHO says. Another US death - that of a 16-month-old - is being investigated for swine flu.


Clic here to read the story from its source.